Coexistence of a congenital giant hairy nevus and extensive vitiligo [1]

Dermatology

Volumn 207, Issue 2, 2003, Pages 199-201

  Grefer, K ^a   Hofmann, M ^a   Sterry, W ^a   Trefzer, Uwe ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Congenital nevus; Giant nevus; Halo; Leukoderma; Melanoma; Vitiligo

Indexed keywords

ADULT; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC IMAGING; DISEASE COURSE; FAMILY HISTORY; FEMALE; HUMAN; LABORATORY TEST; LETTER; NEVUS; PATIENT ATTITUDE; PRIORITY JOURNAL; VITILIGO;

ADOLESCENT; FEMALE; HUMANS; MELANOMA; NEVUS, PIGMENTED; SKIN NEOPLASMS; VITILIGO;

EID: 0041885406     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071796     Document Type: Letter

References (20)

1. Lorentzen M, Pers M, Bretteville-Jensen G: The incidence of malignant transformation in giant pigmented nevi. Scand J Plast Reconstr Surg 1977;11:163-167.
2. Illig L, Weidner F, Hundeiker M, Gartmann H, Biess B, Leyh F, Paul E: Congenital nevi less than or equal to 10 cm as precursors to melanoma: 52 cases, a review, and a new conception. Arch Dermatol 1985;121:1274-1281.
3. Kemp EH, Waterman EA, Weetman AP: Autoimmune aspects of vitiligo. Autoimmunity 2001;34:65-77.
4. Hann SK, Chun WH: Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo; in Hann SK, Nordlund JJ (eds): Vitiligo. Oxford, Blackwell Science, 2000, pp 137-141.
5. Bystryn JC: Serum antibodies in vitiligo patients. Clin Dermatol 1989;7:136-145.
6. Ortonne JP, Bose SK: Vitiligo: Where do we stand? Pigment Cell Res 1993;8:61-72.
7. Schallreuter KU, Levenig C, Berger J: Vitiligo and cutaneous melanoma: A case study. Dermatologica 1991;183:239-245.
8. Lerner AB, Cage GW: Melanoma in horses. Yale J Biol Med 1973;46:646-649.
9. Millikan LE, Hook RR, Manning PJ: Gross and ultrastructural studies in a new melanoma model: The Sinclair swine. Yale J Biol Med 1973;46:631-645.
10. Milton GW, McCarthy WH, Carlon A: Malignant melanoma and vitiligo. Australas J Dermatol 1971;12:131-142.
11. Klaus SN, Lerner AB: Vitiligo. J Am Acad Dermatol 1984;11:997-1000.
12. Itin PH, Lautenschlager S: Acquired leukoderma in congenital pigmented nevus associated with vitiligo-like depigmentation. Pediatr Dermatol 2002;9:73-75.
13. Kestel JL: Giant pigmented nevus with vitiligo. Tex Med 1966;62:52-54.
14. Barriere H, Litoux P, Le Lay M, Bureau B, Stalder JF, Dreno B: Cutaneous achromia and malignant melanoma. Ann Dermatol Vénéréol 1984;111:991-996.
15. Lerner AB, Kirkwood JM: Vitiligo and melanoma: Can genetically abnormal melanocytes result in both vitiligo and melanoma within a single family? J Am Acad Dermatol 1984;11:696-701.
16. Lerner AB, Nordlund JJ: Should vitiligo be induced in patients after resection of primary melanoma? Arch Dermatol 1977;113:421.
17. Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V: High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 1998;188:1203-1208.
18. van den Wijngaard R, Wankowicz-Kalinska A, Pals S, Weening J, Das P: Autoimmune melanocyte destruction in vitiligo. Lab Invest 2001;8:1061-1067.
19. Das PK, van den Wijngaard RM, Wankowicz-Kalinska A, Le Poole IC: A symbiotic concept of autoimmunity and tumour immunity: Lessons from vitiligo. Trends Immunol 2001:22:130-136.
20. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, Fabbri P: New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002;15:87-92.